| To: |
Participating Pharmacies, Physicians, Dentists, Podiatrists, Hospitals and Optometrists
|
| Date: | November 15, 2016 |
| Re: | Epinephrine Auto Injector Update to Preferred Drug List (PDL) |
This notice informs prescribers and providers that the Department of Healthcare and Family Services (HFS) will move the brand name products, EpiPen and EpiPen Jr to non-preferred status.
Beginning with dates of service on and after December 15, 2016, both medications will be non-preferred and require prior authorization. The EpiPen and EpiPen Jr will only be reimbursable when the prescriber can provide medical justification as to why the generic cannot be used.
The generic Epinephrine 0.3mg Auto-Injector and Epinephrine 0.15mg Auto-Injector will remain available without a prior authorization.
Prescribers should begin updating the participant’s prescriptions or submitting prior authorization requests where appropriate at this time to ensure a smooth transition to the generic product.
If you have any questions regarding this provider notice, please contact the Bureau of Professional and Ancillary Services Pharmacy Billing Consultant at 877-782-5565.
Felicia F. Norwood
Director
